This week from Drug Target Review...
EDITOR'S PICK
A research team led by the University of Houston, US has developed a?vaccine?that targets the dangerous synthetic opioid fentanyl, which could block its ability to enter the brain and eliminate the drug’s “high”. According to the scientists, this breakthrough discovery could have major implications for the US opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids.Read more...?
===
WHAT TO READ
The next edition of Drug Target Review goes to press on 1 December. This issue will include In-Depth Focuses on: Immuno-oncology, CRISPR, Upstream Bioprocessing and Screening as well as articles covering Hit-to-Lead, Proteomics and Vaccine Development.
===
TRENDING THIS WEEK
Japanese scientists underwent a study exploring trigeminal nerves and how the intranasal administration of the novel glucagon-like peptide-2 can produce antidepressant effects in mice.?Read more>>>
Australian researchers have tested a new nasal vaccine in mice, with the potential enhance protection against COVID-19. Read more>>>
US researchers have uncovered the uncapped potential that gut-friendly bacteria has for improving treatments of inflammatory bowel disease (IBD).?Read more>>>
领英推荐
In this article,?Drug Target Review’s?Ria Kakkad shares some of the most recent progress in discovering a drug for COPD, a disease that remains a major challenge in the medical industry. Read more>>>
===
WHAT TO WATCH
Ranging from decoding cancer inflammation to engineering cell lines and everything in between - discover our range of upcoming?live webinars and on-demand sessions?which are completely?FREE?to join.
===
JOIN THE COMMUNITY
Get your FREE subscription to Drug Target Review to?stay up to date with the?most pressing topics and trends?in?drug discovery and early-phase therapeutic development.
?Cut down on screen time by listening to our podcasts, get intimate during our webinars or sip a cup of coffee whilst flicking through our journal.?As a member, you’ll also gain exclusive access to:
We provide?compelling?content contributed by the world's most respected scientists, key opinion leaders?and influencers.
www.drugtargetreview.com/news/106559/the-nose-brain-pathway-the-intranasal-administration-of-drugs-to-the-cns/